Literature DB >> 23652852

Role of preoperative MR imaging in the evaluation of patients with persistent or recurrent gynaecological malignancies before pelvic exenteration.

Olivio F Donati1, Yulia Lakhman, Evis Sala, Irene A Burger, Hebert A Vargas, Debra A Goldman, Vaagn Andikyan, Kay J Park, Dennis S Chi, Hedvig Hricak.   

Abstract

PURPOSE: To determine the diagnostic performance of MRI in assessing local tumour extent and evaluate associations between MRI features and survival in patients undergoing MRI before pelvic exenteration for persistent or recurrent gynaecological cancers. METHODS AND MATERIALS: The study included 50 patients with persistent or recurrent gynaecological malignancies who underwent pelvic exenteration between January 1999 and December 2011 and had MRI at most 90 days before surgery. Two radiologists independently assessed invasion of adjacent organs (on a 5-point scale). Diagnostic accuracy, inter-reader agreement, and associations between organ invasion on MRI and patient survival were evaluated.
RESULTS: Areas under receiver operating characteristic curves (AUCs) for invasion of the bladder, rectum and pelvic sidewall were 0.96, 0.90 and 0.98 for reader 1 and 0.95, 0.88 and 0.90 for reader 2. Corresponding sensitivities/specificities were 87.0 %/92.6 %, 81.3 %/97.0 % and 87.5 %/97.2 % for reader 1, and 87.0 %/100.0 %, 75.0 %/97.0 % and 75.0 %/94.4 % for reader 2. Inter-reader agreement was excellent for organ invasion (κ = 0.81-0.85). Pelvic sidewall invasion on MRI was associated with overall and recurrence-free survival (P = 0.01-0.04 for the two readers).
CONCLUSION: Preoperative MRI is accurate in predicting organ invasion. It may guide surgical planning and serve as a predictive biomarker in patients undergoing pelvic exenteration for gynaecological malignancies. KEY POINTS: • MRI can accurately assess bladder and rectal wall invasion before major surgery. • MRI identifies patients requiring extended pelvic exenteration by detecting sidewall invasion. • Inter-reader agreement for detecting organ invasion and tumor size is excellent. • Pelvic sidewall invasion on MRI is associated with shorter overall and recurrence-free survival.

Entities:  

Mesh:

Year:  2013        PMID: 23652852     DOI: 10.1007/s00330-013-2875-1

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  28 in total

1.  Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: an update on out of the box surgery.

Authors:  V Andikyan; F Khoury-Collado; Y Sonoda; S R Gerst; K M Alektiar; J S Sandhu; B H Bochner; R R Barakat; P J Boland; D S Chi
Journal:  Gynecol Oncol       Date:  2012-01-28       Impact factor: 5.482

2.  Can MRI rule out bladder and rectal invasion in cervical cancer to help select patients for limited EUA?

Authors:  A G Rockall; S Ghosh; F Alexander-Sefre; S Babar; M T S Younis; S Naz; I J Jacobs; R H Reznek
Journal:  Gynecol Oncol       Date:  2005-11-28       Impact factor: 5.482

3.  Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy.

Authors:  A BRUNSCHWIG
Journal:  Cancer       Date:  1948-07       Impact factor: 6.860

4.  Prognostic factors in pelvic exenteration for gynecological malignancies.

Authors:  G Baiocchi; G C Guimaraes; R A Rosa Oliveira; L Y Kumagai; C C Faloppa; S Aguiar; M D Begnami; F A Soares; A Lopes
Journal:  Eur J Surg Oncol       Date:  2012-07-18       Impact factor: 4.424

5.  Modified pelvic anterior exenteration.

Authors:  H T Ng; Y Y Kan; E S Ho; M S Yen; K C Chao; C C Yuan
Journal:  Int J Gynaecol Obstet       Date:  1995-07       Impact factor: 3.561

6.  Lymph node staging by positron emission tomography in patients with carcinoma of the cervix.

Authors:  P W Grigsby; B A Siegel; F Dehdashti
Journal:  J Clin Oncol       Date:  2001-09-01       Impact factor: 44.544

7.  Recurrent ovarian cancer: use of contrast-enhanced CT and PET/CT to accurately localize tumor recurrence and to predict patients' survival.

Authors:  Evis Sala; Masako Kataoka; Neeta Pandit-Taskar; Nicole Ishill; Svetlana Mironov; Chaya S Moskowitz; Oleg Mironov; Michelle A Collins; Dennis S Chi; Steven Larson; Hedvig Hricak
Journal:  Radiology       Date:  2010-08-09       Impact factor: 11.105

8.  The role of MR imaging in determining surgical eligibility for pelvic exenteration.

Authors:  M J Popovich; H Hricak; K Sugimura; J L Stern
Journal:  AJR Am J Roentgenol       Date:  1993-03       Impact factor: 3.959

9.  (Laterally) extended endopelvic resection: surgical treatment of locally advanced and recurrent cancer of the uterine cervix and vagina based on ontogenetic anatomy.

Authors:  Michael Höckel; Lars-Christian Horn; Jens Einenkel
Journal:  Gynecol Oncol       Date:  2012-08-01       Impact factor: 5.482

10.  Preoperative assessment of complete tumour resection by magnetic resonance imaging in patients undergoing pelvic exenteration.

Authors:  Dirk Michael Forner; Ansgar Meyer; Bjoern Lampe
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2009-11-17       Impact factor: 2.435

View more
  5 in total

Review 1.  Role of MR Imaging and FDG PET/CT in Selection and Follow-up of Patients Treated with Pelvic Exenteration for Gynecologic Malignancies.

Authors:  Yulia Lakhman; Stephanie Nougaret; Maura Miccò; Chiara Scelzo; Hebert A Vargas; Ramon E Sosa; Elizabeth J Sutton; Dennis S Chi; Hedvig Hricak; Evis Sala
Journal:  Radiographics       Date:  2015 Jul-Aug       Impact factor: 5.333

Review 2.  Primary vaginal cancer: role of MRI in diagnosis, staging and treatment.

Authors:  C S Gardner; J Sunil; A H Klopp; C E Devine; T Sagebiel; C Viswanathan; P R Bhosale
Journal:  Br J Radiol       Date:  2015-05-12       Impact factor: 3.039

3.  Pelvic exenteration for recurrent or persistent gynecologic malignancies: Clinical and histopathologic factors predicting recurrence and survival in a modern cohort.

Authors:  Alli M Straubhar; Andrew J Chi; Qin C Zhou; Alexia Iasonos; Olga T Filippova; Mario M Leitao; Ibraheem O Awowole; Nadeem R Abu-Rustum; Vance A Broach; Elizabeth L Jewell; Jaspreet S Sandhu; Yukio Sonoda
Journal:  Gynecol Oncol       Date:  2021-09-10       Impact factor: 5.482

Review 4.  Patterns of Recurrent Disease in Cervical Cancer.

Authors:  Maura Miccò; Michela Lupinelli; Matteo Mangialardi; Benedetta Gui; Riccardo Manfredi
Journal:  J Pers Med       Date:  2022-05-06

5.  Role of diffusion weighted imaging and contrast-enhanced MRI in the evaluation of intrapelvic recurrence of gynecological malignant tumor.

Authors:  Kazuhiro Kitajima; Utaru Tanaka; Yoshiko Ueno; Tetsuo Maeda; Yuko Suenaga; Satoru Takahashi; Masashi Deguchi; Yoshiya Miyahara; Yasuhiko Ebina; Hideto Yamada; Masakatsu Tsurusaki; Yukihisa Tamaki; Kazuro Sugimura
Journal:  PLoS One       Date:  2015-01-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.